Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (18476)	2/1/1999 8:45:00 PM
From: Mkilloran	Read Replies (2) \| Respond to of 23519

BigKNY3...and after the conf call and published quarterly report I think Charlie O' will issue another statement based on a few new items: ..Reduced expenses ..Reduced inventory ..Balance sheet ..Progress of Muse selling in Sweden, UK by Astra in a market shared with Viagra. ..Progress of Muse selling in Canada by Janssen. I agree that this is for speculative risk oriented accounts... but at current price it offers a large reward for those willing to take the risk. Charlie O' may have a brighter picture by mid year if Vivus delivers a US partner and overseas sales show a reasonable percent of the ED market going towards MUSE vrs Viagra.